tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

MLLCF Stock Latest News

Molecular Partners AG (ADR) trading resumes
The FlyMolecular Partners AG (ADR) trading resumes
14d ago
MOLN
Molecular Partners AG (ADR) trading halted, volatility trading pause
PremiumThe Fly
Molecular Partners AG (ADR) trading halted, volatility trading pause
14d ago
MOLN
Molecular Partners price target raised to CHF 4.50 from CHF 3.70 at JPMorgan
PremiumThe Fly
Molecular Partners price target raised to CHF 4.50 from CHF 3.70 at JPMorgan
22d ago
MOLN
Molecular Partners Reports H1 2024 Corporate Highlights and Financials
PremiumPress Releases
Molecular Partners Reports H1 2024 Corporate Highlights and Financials
25d ago
MOLN
Molecular Partners AG (ADR) trading resumes
PremiumThe Fly
Molecular Partners AG (ADR) trading resumes
2M ago
MOLN
Molecular Partners AG (ADR) trading halted, volatility trading pause
PremiumThe FlyMolecular Partners AG (ADR) trading halted, volatility trading pause
2M ago
MOLN
Molecular Partners AG (ADR) trading resumes
Premium
The Fly
Molecular Partners AG (ADR) trading resumes
3M ago
MOLN
Molecular Partners AG (ADR) trading halted, volatility trading pause
Premium
The Fly
Molecular Partners AG (ADR) trading halted, volatility trading pause
3M ago
MOLN
Molecular Partners to Present at The TD Cowen Radiopharmaceutical Innovation Summit
PremiumPress Releases
Molecular Partners to Present at The TD Cowen Radiopharmaceutical Innovation Summit
3M ago
MOLN
Molecular Partners announces preclinical data from MP0621 trial
PremiumThe Fly
Molecular Partners announces preclinical data from MP0621 trial
3M ago
MOLN
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EHA 2024
PremiumPress Releases
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EHA 2024
3M ago
MOLN
Molecular Partners, Orano Med present MP0712 data at SNMMI
PremiumThe Fly
Molecular Partners, Orano Med present MP0712 data at SNMMI
3M ago
MOLN
Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPin Therapy (RDT) Candidate MP0712 at SNMMI 2024
PremiumPress ReleasesMolecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPin Therapy (RDT) Candidate MP0712 at SNMMI 2024
3M ago
MOLN
Molecular Partners presents data from completed Phase 1 trial of MP0317
Premium
The Fly
Molecular Partners presents data from completed Phase 1 trial of MP0317
4M ago
MOLN
Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin) Monotherapy In Patients With Advanced Solid Tumors At ASCO 2024
Premium
Press Releases
Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin) Monotherapy In Patients With Advanced Solid Tumors At ASCO 2024
4M ago
MOLN
Interim Management Statement Q1 2024 of Molecular Partners: Pipeline Progressing with Two Additional Programs to Enter the Clinic in 2025, Update to MP0533 Program
PremiumPress Releases
Interim Management Statement Q1 2024 of Molecular Partners: Pipeline Progressing with Two Additional Programs to Enter the Clinic in 2025, Update to MP0533 Program
4M ago
MOLN
Molecular Partners Announces Publication in Cancer Immunology Research of Preclinical Data Supporting MP0533’s Proposed Mechanism of Action 
PremiumPress Releases
Molecular Partners Announces Publication in Cancer Immunology Research of Preclinical Data Supporting MP0533’s Proposed Mechanism of Action 
5M ago
MOLN
Life Science Cares Launches in Switzerland
PremiumPress Releases
Life Science Cares Launches in Switzerland
5M ago
MOLN
Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting
PremiumPress Releases
Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting
5M ago
MOLN
Molecular Partners Publishes Invitation to Annual General Meeting 2024
PremiumPress ReleasesMolecular Partners Publishes Invitation to Annual General Meeting 2024
6M ago
MOLN
Molecular Partners Reports Corporate Highlights From Q4 2023 and Key Financials for Full Year 2023
Premium
Press Releases
Molecular Partners Reports Corporate Highlights From Q4 2023 and Key Financials for Full Year 2023
6M ago
MOLN
Molecular Partners Announces Dismissal of Class Action Lawsuit
Premium
Press Releases
Molecular Partners Announces Dismissal of Class Action Lawsuit
7M ago
MOLN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >